KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Pacific Biosciences Of California (PACB) over the last 15 years, with Q3 2025 value amounting to $4.4 million.

  • Pacific Biosciences Of California's Non-Current Deffered Revenue fell 2000.0% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of $5.9 million for FY2024, which is 669.08% up from last year.
  • Pacific Biosciences Of California's Non-Current Deffered Revenue amounted to $4.4 million in Q3 2025, which was down 2000.0% from $5.7 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Non-Current Deffered Revenue registered a high of $25.2 million during Q1 2022, and its lowest value of $1.8 million during Q3 2022.
  • Over the past 5 years, Pacific Biosciences Of California's median Non-Current Deffered Revenue value was $5.7 million (recorded in 2021), while the average stood at $7.7 million.
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first surged by 149751.28% in 2021, then plummeted by 9283.8% in 2022.
  • Pacific Biosciences Of California's Non-Current Deffered Revenue (Quarter) stood at $25.0 million in 2021, then plummeted by 92.84% to $1.8 million in 2022, then surged by 208.25% to $5.5 million in 2023, then increased by 6.69% to $5.9 million in 2024, then decreased by 25.42% to $4.4 million in 2025.
  • Its Non-Current Deffered Revenue was $4.4 million in Q3 2025, compared to $5.7 million in Q2 2025 and $5.9 million in Q1 2025.